LAVAL, Quebec, Aug. 30, 2016 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. VRX VRX ("Valeant" or the "Company") today announced that Joseph C. Papa, Chairman and CEO, will participate in the following healthcare conferences in September:
- Wells Fargo Healthcare Conference on Wednesday, September 7, at 3:30 p.m. ET at the Westin Waterfront Hotel in Boston; and,
- Morgan Stanley Global Healthcare Conference on Tuesday, September 13, at 9:10 a.m. ET at the Grand Hyatt Hotel in New York City.
A live webcast and audio archive of the events will be available on Valeant's Investor Relations website and via this URL: http://ir.valeant.com/events-and-presentations/2016.
About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX:VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.
Contact Information:
Investors:
Elif McDonald
elif.mcdonald@valeant.com
514-856-3855
877-281-6642 (toll free)
Media:
Renée Soto
or
Chris Kittredge/Jared Levy
Sard Verbinnen & Co.
212-687-8080
Logo - http://photos.prnewswire.com/prnh/20101025/LA87217LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/valeant-pharmaceuticals-to-participate-in-september-healthcare-conferences-300320360.html
SOURCE Valeant Pharmaceuticals International, Inc.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.